Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans
about
Tipping the balance both ways: drug resistance and virulence in Candida glabrataGain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulenceThe role of compensatory mutations in the emergence of drug resistanceAcquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistanceGlobal analysis of the evolution and mechanism of echinocandin resistance in Candida glabrataGenetic and genomic architecture of the evolution of resistance to antifungal drug combinationsCryptic fitness advantage: diploids invade haploid populations despite lacking any apparent advantage as measured by standard fitness assaysLongitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistanceGenetic Basis of Antifungal Drug ResistanceA Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection.Population genomics of drug resistance in Candida albicans.Regulatory circuitry governing fungal development, drug resistance, and disease.Horizontal gene transfer: a critical viewMode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiaeIn vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profilingSerial passaging of Candida albicans in systemic murine infection suggests that the wild type strain SC5314 is well adapted to the murine kidney.Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.Stress alters rates and types of loss of heterozygosity in Candida albicans.Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus.At least two origins of fungicide resistance in grapevine downy mildew populations.Isolated cell behavior drives the evolution of antibiotic resistanceEvolution of antifungal-drug resistance: mechanisms and pathogen fitness.Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesisThe evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistanceMixed Candida albicans strain populations in colonized and infected mucosal tissues.Multilocus sequence typing of pathogenic Candida species.Efflux-mediated antifungal drug resistance.Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulenceCompensation of fitness costs and reversibility of antibiotic resistance mutations.Antifungal drug resistance among Candida species: mechanisms and clinical impact.Evolutionary dynamics of Candida albicans during in vitro evolution.Ploidy dynamics and evolvability in fungiDifference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.Antifungal resistance does not necessarily affect Candida glabrata fitness.Aneuploidy and isochromosome formation in drug-resistant Candida albicans.Overexpression of the 14alpha-demethylase target gene (CYP51) mediates fungicide resistance in Blumeriella jaapii.
P2860
Q26996199-9ABC1E9B-B406-4685-9BCD-759C11BCDFA7Q27318203-C5FA74DC-065D-4CA5-B2AD-9D63F3A69585Q28469058-C8B207F1-F18C-46CF-B0DD-4B57B5F11483Q28476322-EC259537-A786-4318-A4C2-24F443553E67Q28483785-9AEC7FC3-5366-4D32-82B8-AFCB18BEA099Q28486002-E71A7209-C509-4DDD-A115-979ECDCBDB79Q28741669-0C84B83D-E82E-4DFF-B093-08589B3FD086Q30044965-C899B95F-9533-4AEF-B47B-CD21B1ED4387Q30434904-60DF1986-5332-4714-9817-9D84F033DFF9Q30844823-C1CD3EEE-2FD6-494B-8835-DEB3E6308154Q34034817-9258E575-2959-42E5-8C19-13EA768234E0Q34190284-BE5FC5B3-8ABB-40EB-8714-72BA735B0807Q34220245-29E18D09-DA46-45C3-A7D9-9617522D624CQ34617356-D7943770-D7A9-4E43-A40D-0901A4B3B281Q34721706-8F7FA902-43F5-43F0-9DD1-723FB81C739BQ34758807-EE0926B9-D4B3-4BA7-A50A-C5F7552A0FFAQ35073460-097108BA-2173-468F-A274-2525B64C503CQ35128582-A05F652E-F6F9-4F28-8D58-FC137889BEC8Q35129428-5C3F376B-5277-46A4-B0E9-67E9F2C351D3Q35673582-CB39F72C-4A47-4FE5-BF05-D4240C2E898BQ35946705-D238C730-EF21-4EB4-A714-BF419111F43BQ35991497-87FFA12B-104E-4D19-B3E6-CFF1B51E5A5CQ36161987-9B043AFD-AE32-4942-9FEB-21D5BA001F37Q36336204-32F9B324-8462-4D00-85D2-7A794CE9DEC1Q36482736-8C7A56AD-7B6A-47E3-93EB-4ADD9B792A29Q36826923-3EE38494-AFAE-47D3-872B-0274608AA4DEQ37075845-364812A5-D882-4CF8-AB02-3338DC60C07CQ37122826-7F2AD20B-73EF-45D9-998B-F3A293F44C11Q37154342-2B14E96F-99ED-4D21-9152-FBD973B3E4E4Q37154596-C2E3F78F-4182-4E61-AF89-74A7484BDCF7Q37156645-48C107E1-85D8-47C9-93FD-23929559E22BQ37545098-73E77581-2A78-45AC-9809-FD4FE6A60C97Q37696851-55BDB41D-D3E0-4DA5-8D66-F90BB4C6164AQ38511946-09E88317-882A-4C87-81A4-50375EC6F7D5Q38955748-8F1E1552-F4C6-4EC3-9E79-37E463593546Q39084067-D6BE6B2B-A282-4E8A-AAF0-63B6D883A276Q39537988-6F2261E5-C233-4DB1-A426-5E00A144C2F2Q42006463-BF4E58A4-9C79-4EAB-80A6-BEA6FD248B37Q42113364-184A7436-17D6-40F8-B86D-1B04D429190FQ42726098-1BF5C9EF-ACAC-4C88-865D-114344D47E63
P2860
Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Divergence in fitness and evol ...... opulations of Candida albicans
@ast
Divergence in fitness and evol ...... opulations of Candida albicans
@en
type
label
Divergence in fitness and evol ...... opulations of Candida albicans
@ast
Divergence in fitness and evol ...... opulations of Candida albicans
@en
prefLabel
Divergence in fitness and evol ...... opulations of Candida albicans
@ast
Divergence in fitness and evol ...... opulations of Candida albicans
@en
P2093
P2860
P1476
Divergence in fitness and evol ...... opulations of Candida albicans
@en
P2093
P2860
P304
P356
10.1128/JB.183.10.2971-2978.2001
P407
P577
2001-05-01T00:00:00Z